We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ACHL market cap is 0. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2023 | |||
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.09M | |||
| Operating Income | -17.46M | |||
| Net Income | -17.51M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 531k | 3.13M | 7.32M |
| Operating Income | -13.76M | -33.2M | -61.06M | -71.13M |
| Net Income | -13.99M | -33.2M | -61.1M | -71.18M |
| Quarter End | Mar 2023 | |||
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 207.64M | |||
| Total Liabilities | 22.46M | |||
| Total Equity | 185.17M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 105.21M | 218.92M | 317.11M | 220.36M |
| Total Liabilities | 3.86M | 29.55M | 27.58M | 23.31M |
| Total Equity | 101.35M | 189.37M | 289.53M | 197.04M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 0 |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.03 (3.49%) |
| Company Name | Achilles Therapeutics PLC |
| Address |
245 hammersmith road london W6 8PW |
| Website | https://www.achillestx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
